No abstract

A method to coat plastic catheters with bioactive silver nanoparticles was developed. These catheters are non-toxic and are capable of targeted and sustained release of silver at the implantation site. Because of their demonstrated antimicrobial properties, they may be useful in reducing the risk of infectious complications in patients with indwelling catheters.

Ti surface was modified to simultaneously improve bone cell materials and antimicrobial activities. Titanium surface was first anodized in sodium fluoride and sulfuric acid electrolytic solution to form titania nanotube on the surface to improve the biocompatibility of the surface. Silver was electrodeposited on the titania nanotube surface at 5 V. Silver added titania nanotube surface was tested for compatibility with bone-cell materials interactions using human osteoblast bone cells. The antibacterial effect was studied using Pseudomonas aeruginosa. Our results show that silver-treated titania nanotube surface may provide antibacterial properties to prevent implants against postoperative infections without interference to the attachment and proliferation of bone tissue on titanium, which is commonly used in dental and orthopedic surgical procedures.

No abstract

SummaryThe immunologic mechanism of protective immunity to the intracdlular parasite Listeria monocytogenes (Lm) is not well understood, however, antilisterial immunity can be adoptively transferred with T lymphocytes from Lm-immune donors. The Lm-immune cells are believed to produce macrophage-activating lymphokines, which leads to the eventual macrophage-dependent eradication of the bacterium. Increasing evidence suggests that immunity to Lm resides exclusively within the CD8 + T cell subset. It is possible that the Lm-immune CD8 + T cells function to release sequestered Lm from nonprofessional phagocytes to awaiting activated macrophage populations. This study was conducted to determine iflisteriolysin O (LLO), which is an essential determinant of Lm pathogenicity, is also a target of the antilisterial immune response. We have found that target calls infected with a LLO + Lm strain are lysed by Lm-immune cytotoxic cells, whereas target cells infected with a LLO-Lm mutant, or pulsed with a heat-killed Lm preparation, are not lysed by the Lm-immune effector cells. We have used a Bacillus subtilis (Bs) construct that expresses the LLO gene product and found that target cells infected with the LLO + Bs construct are lysed by antilisterial cytotoxic cells. The antilisterial cytotoxic response is targeted against LLO, in that we have also used a Bs construct that expresses the perfringolysin (PLO) gene product and found that target cells infected with the PLO + Bs are not lysed by antilisterial cytotoxic effector cells. These data strongly suggest that LLO is a target antigen of antilisterial immunity and may represent the dominant target during the expression of the immune response to Lm.